These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 21494176

  • 21. Application of multipotent mesenchymal stromal cells in pediatric patients following allogeneic stem cell transplantation.
    Müller I, Kordowich S, Holzwarth C, Isensee G, Lang P, Neunhoeffer F, Dominici M, Greil J, Handgretinger R.
    Blood Cells Mol Dis; 2008; 40(1):25-32. PubMed ID: 17869550
    [Abstract] [Full Text] [Related]

  • 22. A Phase I Study to Evaluate Two Doses of Wharton's Jelly-Derived Mesenchymal Stromal Cells for the Treatment of De Novo High-Risk or Steroid-Refractory Acute Graft Versus Host Disease.
    Soder RP, Dawn B, Weiss ML, Dunavin N, Weir S, Mitchell J, Li M, Shune L, Singh AK, Ganguly S, Morrison M, Abdelhakim H, Godwin AK, Abhyankar S, McGuirk J.
    Stem Cell Rev Rep; 2020 Oct; 16(5):979-991. PubMed ID: 32740891
    [Abstract] [Full Text] [Related]

  • 23. Mesenchymal stem cells: properties and role in clinical bone marrow transplantation.
    Le Blanc K, Ringdén O.
    Curr Opin Immunol; 2006 Oct; 18(5):586-91. PubMed ID: 16879957
    [Abstract] [Full Text] [Related]

  • 24. Human umbilical cord-derived mesenchymal stromal cells for the treatment of steroid refractory grades III-IV acute graft-versus-host disease with long-term follow-up.
    Niu JW, Li Y, Xu C, Sheng H, Tian C, Ning H, Hu J, Chen J, Li B, Wang J, Lou X, Liu N, Su Y, Sun Y, Qiao Z, Wang L, Zhang Y, Lan S, Xie J, Ren J, Peng B, Wang S, Shi Y, Zhao L, Zhang Y, Chen H, Zhang B, Hu L.
    Front Immunol; 2024 Oct; 15():1436653. PubMed ID: 39211037
    [Abstract] [Full Text] [Related]

  • 25. Isolation and characterization of mesenchymal stem cells from human umbilical cord blood: reevaluation of critical factors for successful isolation and high ability to proliferate and differentiate to chondrocytes as compared to mesenchymal stem cells from bone marrow and adipose tissue.
    Zhang X, Hirai M, Cantero S, Ciubotariu R, Dobrila L, Hirsh A, Igura K, Satoh H, Yokomi I, Nishimura T, Yamaguchi S, Yoshimura K, Rubinstein P, Takahashi TA.
    J Cell Biochem; 2011 Apr; 112(4):1206-18. PubMed ID: 21312238
    [Abstract] [Full Text] [Related]

  • 26. [Clinical study of umbilical cord-derived mesenchymal stem cells for treatment of nineteen patients with steroid-resistant severe acute graft-versus-host disease].
    Chen GH, Yang T, Tian H, Qiao M, Liu HW, Fu CC, Miao M, Jin ZM, Tang XW, Han Y, He GS, Zhang XH, Ma X, Chen F, Hu XH, Xue SL, Wang Y, Qiu HY, Sun AN, Chen ZZ, Wu DP.
    Zhonghua Xue Ye Xue Za Zhi; 2012 Apr; 33(4):303-6. PubMed ID: 22781723
    [Abstract] [Full Text] [Related]

  • 27. Multiple infusions of mesenchymal stromal cells induce sustained remission in children with steroid-refractory, grade III-IV acute graft-versus-host disease.
    Ball LM, Bernardo ME, Roelofs H, van Tol MJ, Contoli B, Zwaginga JJ, Avanzini MA, Conforti A, Bertaina A, Giorgiani G, Jol-van der Zijde CM, Zecca M, Le Blanc K, Frassoni F, Egeler RM, Fibbe WE, Lankester AC, Locatelli F.
    Br J Haematol; 2013 Nov; 163(4):501-9. PubMed ID: 23992039
    [Abstract] [Full Text] [Related]

  • 28. Gastrointestinal acute graft-versus-host disease in children: histology for diagnosis, mesenchymal stromal cells for treatment, and biomarkers for prediction of response.
    Calkoen FG, Jol-van der Zijde CM, Mearin ML, Schweizer JJ, Jansen-Hoogendijk AM, Roelofs H, van Halteren AG, Egeler RM, van Tol MJ, Ball LM.
    Biol Blood Marrow Transplant; 2013 Nov; 19(11):1590-9. PubMed ID: 23994245
    [Abstract] [Full Text] [Related]

  • 29. Acute gastrointestinal graft-versus-host disease in pediatric patients: serum albumin on day 5 from initiation of therapy correlates with nonrelapse mortality and overall survival.
    Goussetis E, Paisiou A, Kitra V, Peristeri I, Vessalas G, Stefanaki K, Panayotou I, Giamaiou K, Kontou E, Kitzoni M, Dimopoulou MN, Karkelis S, Kafritsa Y, Rapsomaniki E, Papassotiriou I, Tsirigotis P, Roma E, Graphakos S.
    Biol Blood Marrow Transplant; 2011 Jul; 17(7):1058-66. PubMed ID: 21073975
    [Abstract] [Full Text] [Related]

  • 30. [Curative effect of human umbilical cord mesenchymal stem cells for treatment of acute graft-versus-host disease of children after allo-HSCT].
    Qiao SM, Chen GH, Wang Y, Hu SY, Sun XD, Wu DP.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):716-20. PubMed ID: 23815929
    [Abstract] [Full Text] [Related]

  • 31. Mesenchymal stromal cells from pooled mononuclear cells of multiple bone marrow donors as rescue therapy in pediatric severe steroid-refractory graft-versus-host disease: a multicenter survey.
    Kuçi Z, Bönig H, Kreyenberg H, Bunos M, Jauch A, Janssen JW, Škifić M, Michel K, Eising B, Lucchini G, Bakhtiar S, Greil J, Lang P, Basu O, von Luettichau I, Schulz A, Sykora KW, Jarisch A, Soerensen J, Salzmann-Manrique E, Seifried E, Klingebiel T, Bader P, Kuçi S.
    Haematologica; 2016 Aug; 101(8):985-94. PubMed ID: 27175026
    [Abstract] [Full Text] [Related]

  • 32. Xenogeneic immunosuppression of human umbilical cord mesenchymal stem cells in a major histocompatibility complex-mismatched allogeneic acute graft-versus-host disease murine model.
    Guo J, Yang J, Cao G, Fan H, Guo C, Ma YE, Qian Y, Chen L, Li X, Chang C.
    Eur J Haematol; 2011 Sep; 87(3):235-43. PubMed ID: 21535158
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Characterization and gene transfer in mesenchymal stem cells derived from human umbilical-cord blood.
    Lu FZ, Fujino M, Kitazawa Y, Uyama T, Hara Y, Funeshima N, Jiang JY, Umezawa A, Li XK.
    J Lab Clin Med; 2005 Nov; 146(5):271-8. PubMed ID: 16242526
    [Abstract] [Full Text] [Related]

  • 35. Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease.
    Yañez R, Lamana ML, García-Castro J, Colmenero I, Ramírez M, Bueren JA.
    Stem Cells; 2006 Nov; 24(11):2582-91. PubMed ID: 16873762
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Treatment of steroid-resistant acute graft-versus-host disease with anti-thymocyte globulin.
    Khoury H, Kashyap A, Adkins DR, Brown RA, Miller G, Vij R, Westervelt P, Trinkaus K, Goodnough LT, Hayashi RJ, Parker P, Forman SJ, DiPersio JF.
    Bone Marrow Transplant; 2001 May; 27(10):1059-64. PubMed ID: 11438821
    [Abstract] [Full Text] [Related]

  • 38. Extracorporeal photopheresis for steroid resistant graft versus host disease in pediatric patients: a pilot single institution report.
    Berger M, Pessolano R, Albiani R, Asaftei S, Barat V, Carraro F, Biasin E, Madon E, Fagioli F.
    J Pediatr Hematol Oncol; 2007 Oct; 29(10):678-87. PubMed ID: 17921848
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Quantification and immunophenotypic characterization of bone marrow and umbilical cord blood mesenchymal stem cells by multicolor flow cytometry.
    Martins AA, Paiva A, Morgado JM, Gomes A, Pais ML.
    Transplant Proc; 2009 Apr; 41(3):943-6. PubMed ID: 19376394
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.